A phase 3 study of first-line sotorasib, panitumumab, and FOLFIRI versus FOLFIRI with or without bevacizumab-awwb for patients with KRAS G12C–mutated metastatic colorectal cancer (CodeBreaK 301). This ...
Liquid biopsy detection of structural variant breakpoints to monitor ovarian cancer clonal evolution. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I. This abstract does not ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results